The scope of work for this contract includes the following development essentials: CMC development, pre-clinical and clinical studies, device development activities, human factors testing, market…
Active Definitive Contract Awarded Last action
- Contract number
- 75A50125C00018
- Awardee
-
Rafa Laboratories LTD UEI CKDNTKNDPMJ6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $11,997,762
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Solicitation · BAA23100SOL00004 · Posted Sep 26, 2023
- Contract value 8% obligated
-
- $11,997,762.00 Current, with exercised options
- $147,733,954.00 Potential, with all options
- Completion date 10% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Israel
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $230,350 | |
| Original award | $11,767,412 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a $147.73 million firm-fixed-price definitive contract to Rafa Laboratories LTD for medical countermeasure development on September 29, 2025, with no set-aside designation.
The originating solicitation, posted by the Biomedical Advanced Research and Development Authority (BARDA) under the Department of Health and Human Services, requested advanced research and development proposals for medical countermeasures against chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases. The scope of work for this contract includes CMC development, pre-clinical and clinical studies, device development activities, human factors testing, and market viability assessments along with all associated regulatory activities.
Place of performance is Israel. The contract runs through June 30, 2036. The underlying solicitation was posted September 26, 2023, with a proposal due date of September 25, 2028, and contemplated multiple awards across various contract types and values based on program priorities and technical merit. Evaluation criteria emphasized technical merit and importance to agency programs, along with offeror capabilities, cost realism, and past performance.
Description
The scope of work for this contract includes the following development essentials: CMC development, pre-clinical and clinical studies, device development activities, human factors testing, market viability assessments along with all associated regula
Quick answers
Who was awarded contract 75A50125C00018?
75A50125C00018 was awarded to Rafa Laboratories LTD by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 29, 2025.
How much is contract 75A50125C00018 worth?
The government has obligated $11,997,762 on 75A50125C00018. Its potential value, with all options, is $147,733,954.
Was contract 75A50125C00018 competed?
The extent of competition for 75A50125C00018 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award